Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion type Assertion NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_head.
- NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion description "[In previous studies, we demonstrated that rat insulin promoter (RIP)-driven gene therapy successfully targeted human pancreatic tumor PANC-1 cells and mouse insulinoma NIT-1 cells, which are both pancreatic duodenal homeobox-1 (PDX-1)-positive.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_provenance.
- NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion evidence source_evidence_literature NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_provenance.
- NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion SIO_000772 15706433 NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_provenance.
- NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion wasDerivedFrom befree-2016 NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_provenance.
- NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_assertion wasGeneratedBy ECO_0000203 NP480616.RAdfG_NHucU2-8gqKc0Y98-wcOqLpTzcpcLy6WSpOl8Jc130_provenance.